Mahmoud EA,
Moneim WA, Shaker OG, Ghalwash. Ghalwash DM. Expression of endocan and vascular
endothelial growth factor in recurrent minor aphthous ulcers. J Clin Exp Dent.
2019;11(6):e534-41.
doi:10.4317/jced.55695
http://dx.doi.org/10.4317/jced.55695
__________________________________________________________________________________________________________________________________
References
|
1. Scully C, Porter S. Oral
mucosal disease: recurrent aphthous stomatitis. Br J Oral
Maxillofac Surg. 2008;46:198-206 |
|
|
|
|
|
2. Slebioda Z, Szponar E,
Kowalska A. Etiopathogenesis of recurrent aphthous stomatitis and the role of
immunologic aspects: literature review. Arch. Immunol. Ther. Exp.
2014;62:205-215 |
|
|
|
|
|
3. Senovilla L, Galluzzi L,
Zitvogel L, Kroemer G. Immunosurveillance as a regulator of tissue
homeostasis. Trends Immunol. Trends Immunol. 2013;34:471-81. |
|
|
|
|
|
4. Jurge S, Kuffer R, Scully
C, Porter SR. Mucosal Diseases Series, Number VI Recurrent aphthous
stomatitis. Oral
Dis. 2006;12:1-21. |
|
|
|
|
|
5. Koybasi S, Parlak AH,
Serin E, Yilmaz F, Serin D. Recurrent aphthous stomatitis: investigation of
possible etiologic factors. Am J Otolaryngol. 2006;27:229-232 |
|
|
|
|
|
6. Bilgili SG, Ozkol H,
Takci Z, Ozkol HU, Karadag AS, Aslan M. Assessment of the serum paraoxonase
activity and oxidant/antioxidant status in patients with recurrent aphthous
stomatitis. Int
J Dermatol. 2013;52:1259-64. |
|
|
|
|
|
7. Arafa MG, Ghalwash D,
El-Kersh DM, Elmazar MM. Propolis-based niosomes as oromuco-adhesive films: A
randomized clinical trial of a therapeutic drug delivery platform for the
treatment of oral recurrent aphthous ulcers. Scientific Reports. 2018;8:18056 |
|
|
|
|
|
8. Ship JA, Chavez EM, Doerr
PA, Henson BS, Sarmadi M. Recurrent aphthous stomatitis. Quintessence Int.
2000;31:95-112. PMid:11203919 |
|
|
|
|
|
9. Scully C, Gorsky M,
Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis:
a consensus approach. J Am Dent Assoc. 2003;134:200-207 |
|
|
|
|
|
10.
Eguia-del Valle A, Martinez-Conde-Llamosas R, López-Vicente J,
Uribarri-Etxebarria A, Aguirre-Urizar JM. Salivary levels of Tumour Necrosis Factor-alpha in patients with
recurrent aphthous stomatitis. Med Oral Patol Oral Cir Bucal.
2011;16:e33-6. |
|
|
|
|
|
11. Cekmen M, Evereklioglu
C, Er H, Inalöz HS, Doganay S. Vascular endothelial growth factor levels are
increased and associated with disease activity in patients with Behçet's
syndrome. Int
J Dermatol. 2003;42:870-875. |
|
|
|
|
|
12.
Harada M, Mitsuyama K, Yoshida H, Sakisaka S, Taniguchi E, Kawaguchi T, et
al. Vascular endothelial growth factor in patients with
rheumatoid arthritis. Scand J Rheumatol. 1998;27:377-80. |
|
|
|
|
|
13. Terai M, Yasukawa K,
Narumoto S, Tateno S, Oana S, Kohno Y. Vascular endothelial growth factor in
acute Kawasaki disease. Am
J Cardiol. 1999;83:337-9. PMid:10072219 |
|
|
|
|
|
14. Arbiser JL, Johnson D,
Cohen C, Brown LF. High-Level Expression of Vascular Endothelial Growth
Factor and Its Receptors in an Aphthous Ulcer. JCMS. 2003;7:225. |
|
|
|
|
|
15. Lassalle P, Molet S,
Janin A, Heyden JV, Tavernier J, Fiers W, et al. ESM-1 is a novel human
endothelial cell-specific molecule expressed in lung and regulated by
cytokines. J Biol Chem. 1996;271:20458-20464.
https://doi.org/10.1074/jbc.271.34.20458 |
|
|
|
|
|
16. Zhang SM, Zuo L, Zhou Q,
Gui SY, Shi R, Wu Q, et al. Expression and distribution of endocan in human
tissues. Biotech
Histochem. 2012; 87:172-8. |
|
|
|
|
|
17. Sarrazin S, Adam E, Lyon
M, Depontieu F, Motte V, Landolfi C, et al. Endocan orendothelial cell
specific molecule-1 (ESM-1): apotential novel endothelial cell marker and
anew target for cancer therapy. BiochimBiophys Acta. 2006;1765: 25-37. |
|
|
|
|
|
18. Delehedde M, Devenyns L,
Maurage CA, Vivès RR. Endocan in cancers: A lesson from a circulating dermatan
sulfate proteoglycan. Int J Cell Biol. 2013;2013:705027. |
|
|
|
|
|
19. Spafford MF, Koch WM,
Reed AL, Califano JA, Xu LH, Eisenberger CF, et al. Detection of Head and
Neck Squamous Cell Carcinoma among Exfoliated Oral Mucosal Cells by
Microsatellite. Analysis
Clin Cancer Res. 2001;7:607-12. PMid:11297256 |
|
|
|
|
|
20. Borra RC, Andrade PM,
Silva ID, Morgun A, Weckx LLM, Smirnova AS, et al. The Th1/Th2 immune type
response of the recurrent aphthous ulceration analyzed by cDNA microarray. J
Oral Pathol Med. 2004;33:140-146 |
|
|
|
|
|
21. Lewkowicz N, Banasik M,
Tcho'rzewski H. Predominance of production of Th1 type cytokines in recurrent
aphthous ulceration. Dent
Med Probl. 2004;42:655-60. PMid:15894112 |
|
|
|
|
|
22. Nowak M, Go'rska R.
Comparison of IL-2 concentration in peripheral blood and stimulated saliva
found in individuals suffering from recurrent aphthous stomatitis (RAS) and
in healthy ones. Czas
Stomatol. 2008;61:387-94. |
|
|
|
|
|
23. Turer CC, Durmusx D,
Balli U, Guven B. Effect of Non-Surgical Periodontal Treatment on Gingival
Crevicular Fluid and Serum Endocan, Vascular Endothelial Growth Factor-A, and
Tumor Necrosis Factor-Alpha Levels J Periodontol. 2017;88:493-501. |
|
|
|
|
|
24.
Albanidou-Farmaki E, Markopoulos AK, Kalogerakou F, Antoniades DZ. Detection, enumeration and characterization of T
helper cells secreting type 1 and type 2 cytokines in patients with recurrent
aphthous stomatitis. Tohoku
J Exp Med. 2007;212:101-5. |
|
|
|
|
|
25. Lewkowicz N, Kur B,
Kurnatowska A, Tchorzewski H, Lewkowicz P. Expression of Th1/
Th2/Th3/Th17-related genes in recurrent aphthous ulcers. Arch Immunol Ther
Exp. 2011;59:399-406. |
|
|
|
|
|
26. Shibuya M. Vascular
endothelial growth factor and its receptor system: Physiological functions in
angiogenesis and pathological roles in various diseases. J Biochem.
2013;153:13-9. |
|
|
|
|
|
27. Balta I, Balta S,
Koryurek OM, Demirkol S, Mikhailidis DP. Serum endocan levels as a marker of
disease activity in patients with Behçet disease. J Am Acad Dermatol.
2014;70:291-6. |
|
|
|
|
|
28.
Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T,
et al. Endocan, a new endothelial marker in humansepsis.
Crit Care Med. 2006;34:532-7. |
|
|
|
|
|
29. Balta S, Demirkol S,
Celik T, Kucuk U, Unlu M. Association between coronary artery ectasia and
neutrophil-lymphocyte ratio. Angiology. 2013;64:627-32. |
|
|
|
|
|
30.
Yilmaz MI, Siriopol D, Saglam M, Cayci T, Acikel C, Unal HU, et al. Plasma endocan levels associate with inflammation,
vascular abnormalities, cardiovascular events, and survival in chronic kidney
disease. Kidney
Int. 2014;86:1213-20. |
|
|
|
|
|
31. Rennel E, Mellberg S,
Dimberg A, Petersson L, Botling J, Ameur A, et al. Endocan is a VEGF-A and
PI3K regulated gene with increased expression in human renal cancer. Exp Cell Res.
2007;313:1285-94. |
|
|
|
|
|
32. Sarrazin S, Maurage CA,
Delmas D, Lassalle P, Delehedde M. Endocan as a biomarker of endothelial
dysfunction in cancer. J Cancer Sci Ther. 2010;2:47-52. |
|
|
|
|
|
33. Taylor J, Glenny AM,
Walsh T, Brocklehurst P, Riley P, Gorodkin R, et al. Interventions for the
management of oral ulcers in Behcet's disease. Cochrane Database Syst Rev.
2014;9:CD011018. PMid:25254615 |
|
|
|
|
|
34. Béchard D, Scherpereel
A, Hammad H, Gentina T, Tsicopoulos A, Aumercier, et al. Human
Endothelial-Cell Specific Molecule-1 Binds Directly to the Integrin
CD11a/CD18 (LFA-1) and Blocks Binding to Intercellular Adhesion Molecule-1. J Immunol.
2001;167:3099-3106. |
|
|
|
|
|
35. Zhou X, Lai X, Mu D,
Gong J, Yin Q. The Role of Endocan in the Development of Hepatocellular
Carcinoma. American Journal of Cancer Prevention. 2016;4:57-63. PMid:26755884
PMCid:PMC4698501 |
|
|
|
|
|
36.
Munoz-Corcuera M, Esparza-Gomez G, Gonzalez-Moles MA, Bascones-Martinez A.
Oral ulcers: clinical aspects. A tool for
dermatologists. Part II. Chronic ulcers. Clin Exp Dermatol. 2009;34:456-61. |
|
|
|
|
|
37. Shaker O, Ay El-Deen MA,
El Hadidi H, Grace BD, El Sherif H. The role of heat shock protein 60,
vascular endothelial growth factor and antiphospholipid antibodies in Behçet
disease. Br
J Dermatol. 2007;156:32-7. |
|
|
|
|
|
38. Yalcin B, Arda N, Tezel
GG, Erman M, Alli N. Expressions of vascular endothelial growth factor and
CD34 in oral aphthous lesions of Behcet's disease. Anal Quant Cytol
Histol. 2006;28:303-6. PMid:17220143 |
|
|
|
|
|
39.
Aterido A, Julià A, Carreira P, Blanco R, López-Longo JJ, Pérez JJ, et al. Genome-wide pathway analysis identifies VEGF pathway
association with oral ulceration in systemic lupus erythematosus Arthritis
Research & Therapy. 2017;19:138. |
|